![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 15, 10019-10023, April 9, 1999
,
, and
From the Departments of In this study we found that macrophage
metalloelastase, MMP-12 cleaves, in vitro,
apolipoprotein(a) (apo(a)) in the
Asn3518-Val3519 bond located in the linker
region between kringles IV-4 and IV-5, a bond immediately upstream of
the Ile3520-Leu3521 bond, shown previously to
be the site of action by neutrophil elastase (NE). We have also shown
that human apo(a) injected into the tail vein of control mice undergoes
degradation as reflected by the appearance of immunoreactive fragments
in the plasma and in the urine of these animals. To define whether
either or both of these enzymes may be responsible for the in
vivo apo(a) cleavage, we injected intravenously
MMP-12
Medicine and of
Biochemistry and Molecular Biology, University of Chicago,
Chicago, Illinois 60637 and the ¶ Department of Medicine,
Washington University, St. Louis, Missouri 63110
/
, NE
/
mice and litter mates,
all of the same strain, with either lipoprotein(a) (Lp(a)), full-length
free apo(a), or its N-terminal fragment, F1, obtained by the in
vitro cleavage of apo(a) by NE. In the plasma of
Lp(a)/apo(a)-injected mice, F1 was detected in control and NE
/
mice but was virtually absent in the
MMP-12
/
mice. Moreover, fragments of the F1 type were
present in the urine of the animals except for the
MMP-12
/
mice. These fragments were significantly
smaller in size than those observed in the plasma. All of the animals
injected with F1 exhibited small sized fragments in their urine. These
observations provide evidence that, in the mouse strain used, MMP-12
plays an important role in the generation of F1 from injected human Lp(a)/apo(a) and that this fragment undergoes further cleavage during
renal transit via a mechanism that is neither NE- nor
MMP-12-dependent. Thus, factors influencing the expression
of MMP-12 may have a modulating action on the biology of Lp(a).
This article has been cited by other articles:
![]() |
J.-S. Kim, J.-H. Chang, H.-K. Yu, J.-H. Ahn, J.-S. Yum, S.-K. Lee, K.-H. Jung, D.-H. Park, Y. Yoon, S.-M. Byun, et al. Inhibition of Angiogenesis and Angiogenesis-dependent Tumor Growth by the Cryptic Kringle Fragments of Human Apolipoprotein(a) J. Biol. Chem., August 1, 2003; 278(31): 29000 - 29008. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Klezovitch, C. Edelstein, and A. M. Scanu Stimulation of Interleukin-8 Production in Human THP-1 Macrophages by Apolipoprotein(a). EVIDENCE FOR A CRITICAL INVOLVEMENT OF ELEMENTS IN ITS C-TERMINAL DOMAIN J. Biol. Chem., December 7, 2001; 276(50): 46864 - 46869. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Edelstein, K. Nakajima, D. Pfaffinger, and A. M. Scanu Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins J. Lipid Res., October 1, 2001; 42(10): 1664 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gonbert, B. Saint-Jore, P. Giral, C. Doucet, J. Chapman, and J. Thillet Molecular Analysis of Apo(a) Fragmentation in Polygenic Hypercholesterolemia: Characterization of a New Plasma Fragment Pattern Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Vu and Z. Werb Matrix metalloproteinases: effectors of development and normal physiology Genes & Dev., September 1, 2000; 14(17): 2123 - 2133. [Full Text] |
||||
![]() |
B. Garner, A. H. Merry, L. Royle, D. J. Harvey, P. M. Rudd, and J. Thillet Structural Elucidation of the N- and O-Glycans of Human Apolipoprotein(a). ROLE OF O-GLYCANS IN CONFERRING PROTEASE RESISTANCE J. Biol. Chem., June 15, 2001; 276(25): 22200 - 22208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |